Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

Thrombosis Research

Volumn 111, Issue 6, 2003, Pages 335-341

  Roschitz, Birgit ^a   Beitzke, Albrecht ^b   Gamillscheg, Andreas ^b   Sudi, Karl ^a   Koestenberger, Martin ^a   Leschnik, Bettina ^a   Muntean, Wolfgang ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c Univ Klin F Kinder und J   (Austria)

Author keywords

Anticoagulation; Cardiac catheterization; Low molecular weight heparin; Pediatrics; Unfractionated heparin

Indexed keywords

D DIMER; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; THROMBIN TIME; THROMBOSIS; TREATMENT OUTCOME;

EID: 0347418180     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.020     Document Type: Article

References (30)

1. Vitiello R., McCrindle B.W., Nykanen D., Freedom R.M., Benson L.N. Complications associated with pediatric cardiac catheterization. J. Am. Coll. Cardiol. 32:1998;1433-1440.
2. Stanger P., Heymann M.A., Tarnoff H., Hoffman J.I., Rudolph A.M. Complications of cardiac catheterization of neonates, infants and children. A three year study. Circulation. 50:1974;595-608.
3. Freed M.D., Keane J.F., Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation. 50:1974;565-569.
4. Girod D.A., Hurwitz R.A., Caldwell R.L. Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Ped. Cardiol. 3:1982;175-180.
5. Netz H., Madu B., Röhner G. Heparinization during percutaneous cardiac catheterization in children. Ped. Cardiol. 8:1987;167-168.
6. Grady R.M., Eisenberg P.R., Bridges N.D. Rational approach to use of heparin during cardiac catheterization in children. J. Am. Coll. Cardiol. 25:1995;725-729.
7. Saxena A., Gupta R., Kumar R.K., Kothari S.S., Wasir H.S. Predictors of arterial thrombosis in infants and children randomized to two heparin dosages. Catheter. Cardiovasc. Diagn. 41:1997;400-403.
8. Andrew M., Marzinotto V., Blanchette V.et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr. Res. 35:1994;78-83.
9. Andrew M., Ofosu F.A., Schmidt B., Brooker L., Hirsh J., Buchanan M.R. Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thromb. Res. 52:1988;517-527.
10. McDonald M.M., Jacobson L.J., Hay W., Hathaway W.E. Heparin clearance in the newborn. Pediatr. Res. 15:1981;1015-1018.
11. Bull B.S., Korpman R.A., Huse W.M., Briggs B.D. Heparin therapy during extracorporal circulation: I. Problems inherent in existing heparin protocols. J. Thorac. Cardiovasc. Surg. 69:1975;674-684.
12. Prandoni P., Lensing A.W., Buller H.R. A comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal vein thrombosis. Lancet. 339:1992;441-445.
13. Hull R.D., Raskob G.E., Pineo G.F.et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N. Engl. J. Med. 326:1992;975-982.
14. Hirsh J., Levine M.N. Low molecular weight heparin. Blood. 79:1992;1-17.
15. Dix D., Andrew M., Marzinotto V.et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J. Pediatr. 136:2000;439-445.
16. Massicotte P., Adams M., Marzinotto V., Brooker L.A., Andrew M. Low-molecular-weight-heparin in pediatric patients with thrombotic disease: a dose finding study. J. Pediatr. 1996;313-318.
17. Hofmann S., Knoefler R., Lorenz N.et al. Clinical experiences with low molecular weight heparins in pediatric patients. Thromb. Res. 103:2001;345-353.
18. Rabah M.M., Premmereur J., Graham M.et al. Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris. Am. J. Cardiol. 84:1999;1391-1395.
19. Deutsch E. The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory. Am. Heart. J. 138:1999;S577-S578.
20. Beitzke A., Schuchlenz H., Gamillscheg A., Stein J.I., Wendelin G. Catheter closure of the persistent foramen ovale: mid term results in 162 patients. J. Interv. Cardiol. 14:2001;223-229.
21. Andrew M. Anticoagulation and thrombolysis in children. Pediatr. Cardiol. Surg. 19:1992;168-177.
22. Harker L.A., Malpass T.W., Branson H.E., Hessel E.A., Slichter S.J. Mechanisms of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha granule release. Blood. 56:1980;824-834.
23. Andrew M., MacIntyre B., Mac Millan J.et al. Heparin therapy during cardiopulmonary bypass in children requires ongoing quality control. Thromb. Hem. 70:1993;937-941.
24. Girardi L., Sudi K., Muntean W. Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time. Art Org. 24:2000;507-513.
25. Greaves M. Limitations of the laboratory monitoring of heparin therapy. Thromb. Haemost. 87:2002;163-164.
26. Nohe N., Flemmer A., Rumler R., Praun M., Auberger K. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur. J. Pediatr. 158:1999;134-139.
27. Van Biljon I., Van Damme-Lombaerts R., Demol A., Van Geet C., Proesmans W., Arnout J. Low molecular weight heparin for anticoagulation during hemodialysis in children: a preliminary study. Eur. J. Pediatr. 155:1996;70.
28. Broyer M., Gagnadoux M.F., Sierro A.et al. Prevention of vascular thrombosis after renal transplantation using low molecular weight heparin. Ann. Pediatr. 38:1991;397-399.
29. Hashikura Y., Kawasaki S., Okumura N.et al. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation. 60:1995;1109-1112.
30. Collet J.P., Montalescot G., Lison L.et al. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris. Circulation. 103:2001;658-663.